KR810000604B1 - Process for preparing aminoalkexyphenyl derivative - Google Patents

Process for preparing aminoalkexyphenyl derivative Download PDF

Info

Publication number
KR810000604B1
KR810000604B1 KR7800157A KR780000157A KR810000604B1 KR 810000604 B1 KR810000604 B1 KR 810000604B1 KR 7800157 A KR7800157 A KR 7800157A KR 780000157 A KR780000157 A KR 780000157A KR 810000604 B1 KR810000604 B1 KR 810000604B1
Authority
KR
South Korea
Prior art keywords
methyl
phenyl
group
methoxy
isoquinolin
Prior art date
Application number
KR7800157A
Other languages
Korean (ko)
Inventor
하이더 요하힘
아우스텔 폴크하르트
에베르 라인 볼프강
카다츠 루돌프
뎀겐 쥐르겐
코빙거 발터
릴리 크리스챤
Original Assignee
하인즈 쉐플러
닥터 칼로메 지. 엠. 비. 에이치.
요한네스 케크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하인즈 쉐플러, 닥터 칼로메 지. 엠. 비. 에이치., 요한네스 케크 filed Critical 하인즈 쉐플러
Priority to KR7800157A priority Critical patent/KR810000604B1/en
Application granted granted Critical
Publication of KR810000604B1 publication Critical patent/KR810000604B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

New aminoalkoxyphenyl derivs. of formula I[A = lower alkoxy group or substituted benzene or pyridine ring; R1 = H, lower alkyl; R2 = C1-6 straight chain or side chain; R3 =H, OH; R4 = H, lower alkyl or alkoxy; R5 = H, lower alkyl; n = 0,1,2 and their acid added salts were prepd. by reacting of formula II[X = halogen, oxygen and formula III or formula IV and formula V. Title compds. are useful as antiarrhythmic, β- adrenergic recepto blocks and antianginous agents.

Description

아미노알콕시페닐 유도체의 제조방법Method for preparing aminoalkoxyphenyl derivative

본 발명은 가치있는 약학적 활성, 특히 항앙기나성, 항부정맥성 및 β-수용체 차단 효과를 갖는 일반적 구조식(I)의 신규의 아미노알콕시페닐유도체 및 무기 또는 유기산과 생리적으로 경쟁적인 염의 제조방법에 관한 것이다.The present invention relates to a novel aminoalkoxyphenyl derivative of general formula (I) and a physiologically competitive salt with inorganic or organic acids having valuable pharmaceutical activity, in particular antiangina, antiarrhythmic and β-receptor blocking effects. It is about.

Figure kpo00001
Figure kpo00001

상기 구조식에서 A는 저급알콕시그룹, 아미노-및/또는 니트로그룹 또는 피리딜 그룹으로 모노-, 디- 또는 트리치환된 페닐그룹이고 R1은 수소원자 또는 저급알킬기이고 R2는 1 내지 6의 탄소원자를 갖는 직쇄 또는 측쇄알킬 그룹이거나 1 내지 4의 탄소원자를 갖고 하이드록시그룹에 의해 임의로 치환된 직쇄 포화 알킬렌그룹이다. 여기서 알킬렌그룹은 아미노그룹, 2 내지 6의 탄소원자를 갖는 카브알콕시그룹, 페닐 또는 페녹시그룹에 의해 말단 치환된 그룹이고 페닐 또는 페녹시 그룹은 저급 알킬 및/또는 알콕시 기에 의해 모노-, 디-또는 트리 치환된 그룹이다.Wherein A is a mono-, di- or trisubstituted phenyl group with a lower alkoxy group, an amino- and / or nitro group or a pyridyl group, R 1 is a hydrogen atom or a lower alkyl group and R 2 is a carbon source of 1 to 6 Linear or branched alkyl group having a group or a straight chain saturated alkylene group optionally substituted by hydroxy group with 1 to 4 carbon atoms. Wherein the alkylene group is an amino group, a group substituted terminally by a carboalkoxy group having 2 to 6 carbon atoms, a phenyl or phenoxy group and the phenyl or phenoxy group is mono-, di- by a lower alkyl and / or alkoxy group Or a tree substituted group.

R3는 수소원자 또는 하이드록시그룹이고 R4는 수소원자, 저급알킬 또는 알콕시그룹이고 R5는 수소원자 또는 저급알킬그룹이고 n은 0,1 또는 2이다.R 3 is a hydrogen atom or a hydroxy group, R 4 is a hydrogen atom, a lower alkyl or an alkoxy group, R 5 is a hydrogen atom or a lower alkyl group and n is 0, 1 or 2.

따라서 본 발명의 과제는 임의 치환된 아미노알콕시페닐, 아미노알콕시벤질 또는 아미노알콕시페닐에틸그룹에 의해 3-위치에서 치환된 신규의 이소퀴놀린-1(2H)-온, 1,6-, 2,6-, 3,6- 및 4,6-나프티리딘-5(6H)-온 및 무기 또는 유기산과 생리적으로 경쟁적인 산부가염의 제조방법에 관한 것이다.Accordingly, the subject of the present invention is a novel isoquinolin-1 (2H) -one, 1,6-, 2,6 substituted in the 3-position by an optionally substituted aminoalkoxyphenyl, aminoalkoxybenzyl or aminoalkoxyphenylethyl group -, 3,6- and 4,6-naphthyridin-5 (6H) -one and a process for preparing acid addition salts which are physiologically competitive with inorganic or organic acids.

A,R1,R2,R4및 R5의 정의에서 사용된 "저급알킬그룹"은 1 내지 3의 탄소원자를 갖는 알킬그룹, 즉 메틸, 에틸, 프로필 또는 이소프로필그룹을 의미하고 A, R2및 R4의 정의에서 사용된 "저급알콕시그룹"은 1에서 3의 탄소원자를 갖는 알콕시그룹, 즉 메톡시, 에톡시, 프로폭시 또는 이소프로폭시그룹을 나타낸다.“Lower alkyl group” as used in the definitions of A, R 1 , R 2 , R 4 and R 5 means an alkyl group having 1 to 3 carbon atoms, ie, methyl, ethyl, propyl or isopropyl group and A, R “Lower alkoxy group” as used in the definitions of 2 and R 4 represents an alkoxy group having 1 to 3 carbon atoms, ie methoxy, ethoxy, propoxy or isopropoxy group.

아속은 A가 페닐, 메톡시페닐, 디메톡시페닐 또는 피리딜그룹이고 R1이 수소원자, 메틸, 에틸, 프로필 또는 이소프로필 그룹이고 R2가 페닐, 메톡시페닐, 디메톡시페닐, 트리메톡시페닐, 메틸페닐, 아미노 카브메톡시, 카브에톡시, 카브프로폭시, 카보부톡시, 카보펜톡시, 카브이소프로폭시, 카보 3급 부톡시, 카보 3급 페녹시, 메틸페녹시 또는 메톡시페녹시 그룹에 의해 말단 치환된 메틸, 에틸, n-프로필, n-부틸, n-펜틸, n-헥실, 이소프로필, 이소부틸, 이소아밀, 3급 부틸 또는 3급펜틸그룹이거나 메틸렌, 에틸렌, 하이드록시에틸렌, 프로펠렌, 하이드록시 프로펠렌 또는 부틸렌그룹이고 R4가 수소원자, 메톡시, 에톡시, 프로폭시 또는 이소프로폭시그룹이고 R5이 메틸, 에틸, 프로필 또는 이소프로필그룹인 일반적 구조식(I)화합물에 의해 구성된다.Subgenus A is phenyl, methoxyphenyl, dimethoxyphenyl or pyridyl group, R 1 is hydrogen atom, methyl, ethyl, propyl or isopropyl group and R 2 is phenyl, methoxyphenyl, dimethoxyphenyl, trimethoxy Phenyl, methylphenyl, amino carbmethoxy, carethoxy, carbpropoxy, carbobutoxy, carbopentoxy, carbisopropoxy, carbo tert-butoxy, carbo tertiary phenoxy, methylphenoxy or methoxyphenoxy Methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, isopropyl, isobutyl, isoamyl, tertiary butyl or tertiary pentyl groups substituted by groups or are methylene, ethylene, hydroxy General structural formulas wherein ethylene, propylene, hydroxy propylene or butylene groups, R 4 is a hydrogen atom, methoxy, ethoxy, propoxy or isopropoxy group and R 5 is methyl, ethyl, propyl or isopropyl group ( I) is composed of a compound.

일반적 구조식(I)의 바람직한 화합물은 A가 페닐, 메톡시페닐, 디메톡시페닐 또는 피리딜그룹이고 R1이 수소원자, 메틸 또는 에틸그룹이고 R2가 에틸, 이소프로필 또는 3급 부틸그룹이거나 하이드록시 그룹에 의해 임의 치환된 2 또는 3의 탄소원자를 갖는 직쇄 포화알킬렌그룹이다. 여기서 각 그룹은 페닐, 메톡시페닐, 디메톡시페닐, 트리메톡시페틸, 아미노, 메틸페닐, 이소프로폭시카보닐, 3급부톡시카보닐, 페녹시, 메틸페녹시 또는 메톡시페녹시그룹으로 말단 치환된다.Preferred compounds of general formula (I) are those in which A is a phenyl, methoxyphenyl, dimethoxyphenyl or pyridyl group, R 1 is a hydrogen atom, methyl or ethyl group and R 2 is ethyl, isopropyl or tertiary butyl group or It is a straight chain saturated alkylene group having 2 or 3 carbon atoms optionally substituted by a oxy group. Wherein each group is terminally substituted with a phenyl, methoxyphenyl, dimethoxyphenyl, trimethoxyphenyl, amino, methylphenyl, isopropoxycarbonyl, tert-butoxycarbonyl, phenoxy, methylphenoxy or methoxyphenoxy group do.

R3가 수소원자 또는 하이드록시그룹이고 R4가 수소원자 또는 메톡시그룹이고 R5가 메틸그룹이고 n이 0,1 또는 2인 화합물이다.R 3 is a hydrogen atom or a hydroxy group, R 4 is a hydrogen atom or a methoxy group, R 5 is a methyl group and n is 0, 1 or 2.

여기서 R2의 방향족 치환제로서는 특히 페닐, 2-메톡시페닐, 4-메톡시페닐, 3,4-디메톡시페닐, 3,4,5-트리메톡시페닐, 페녹시, 2-메틸페녹시, 4-메틸페녹시, 2-메톡시페녹시 또는 4-메톡시페녹시그룹등이 있다.The aromatic substituents of R 2 here are in particular phenyl, 2-methoxyphenyl, 4-methoxyphenyl, 3,4-dimethoxyphenyl, 3,4,5-trimethoxyphenyl, phenoxy, 2-methylphenoxy , 4-methylphenoxy, 2-methoxyphenoxy or 4-methoxyphenoxy group.

그러나 구조식(I)의 특히 바람직한 화합물은 A가 페닐, 2-메톡시페닐 또는 2,3-디메톡시페닐그룹이고 R1이 수소원자이고 R2가 이소프로필 또는 3급부틸그룹이고 R3가 하이드록시그룹이고 R4가 수소원자 또는 메톡시그룹이고 R5가 메틸그룹이고 n이 0,1 또는 2인 화합물이다.However, particularly preferred compounds of formula (I) are those in which A is a phenyl, 2-methoxyphenyl or 2,3-dimethoxyphenyl group, R 1 is a hydrogen atom, R 2 is isopropyl or tert-butyl group and R 3 is hydroxy A oxy group, R 4 is a hydrogen atom or a methoxy group, R 5 is a methyl group and n is 0, 1 or 2;

상기의 일반적 구조식(I)의 신규의 화합물은 다음의 방법에 따라 제조된다.The novel compounds of general formula (I) above are prepared according to the following methods.

a) 구조식(II)의 프로폭시페닐유도체와 구조식(III)의 아민과의 반응a) Reaction of propoxyphenyl derivative of formula (II) with amine of formula (III)

Figure kpo00002
Figure kpo00002

상기 구조식에서 A,R3,R4,R5및 n와 R1및 R2는 상기 정의된 대로이고 X는 할로겐원자 또는 R3와 함께 산소원자와 같은 친핵적 교환그룹이다.Wherein A, R 3 , R 4 , R 5 and n and R 1 and R 2 are as defined above and X is a nucleophilic exchange group such as an oxygen atom together with a halogen atom or R 3 .

상기의 반응은 알콕시드 또는 알칼리카보네이트와 같은 산결합제의 존재하에서 50 내지 200℃사이의 온도, 바람직하게 80 내지 160℃사이의 온도로 폐용기내의 이소프로판올, 테트라하이드로푸란, 디메틸포름아미드 또는 디메틸설폭시드와 같은 용매내에서 수행된다. 그러나 용매로 사용되는 구조식(III)의 아민이 과량 존재할 경우 유리하다.The reaction is carried out in isopropanol, tetrahydrofuran, dimethylformamide or dimethyl sulfoxide in a waste container at a temperature between 50 and 200 ° C., preferably between 80 and 160 ° C., in the presence of an acid binder such as an alkoxide or alkali carbonate. In a solvent such as However, it is advantageous if the amine of formula (III) used as a solvent is present in excess.

b) 구조식(IV)의 카복실산 또는 그의 반응 유도체와 구조식(V)의 아민과의 반응b) Reaction of the carboxylic acid of formula (IV) or a reaction derivative thereof with the amine of formula (V)

Figure kpo00003
Figure kpo00003

상기식에서 A,R1에서 R4까지 및 R5은 상기 정의된 대로이다.Wherein A, R 1 to R 4 and R 5 are as defined above.

상기의 반응은 알콕시드와 같은 축합제의 존재하에서 50 내지 200℃사이의 온도, 바람직하게 80 내지 140℃사이의 온도로 폐용기내의 메탄올, 에탄올, 이소프로판올, 디옥산 또는 디에틸포름 아미드와 같은 용매내에서 효과적으로 진행된다. 그러나 용매로 구조식(V)의 아민이 과량 사용될 경우 반응은 유리하게 수행된다.The reaction is carried out in the presence of a condensing agent, such as an alkoxide, at a temperature between 50 and 200 ° C., preferably between 80 and 140 ° C. in a waste container such as methanol, ethanol, isopropanol, dioxane or diethylformamide. It is effectively progressed within. However, the reaction is advantageously carried out when an excess of the amine of formula (V) is used as the solvent.

본 발명에 따라 수득된 신규의 구조식(I)화합물은 무기 및 유기산과 생리적으로 경쟁적인 염으로 전환될 수 있다. 적절한 산은 염산, 인산, 취화수소화, 황산, 젖산, 시트르산, 타타르산, 옥살산 및 말레산들이다.The novel compounds of formula (I) obtained according to the invention can be converted into salts which are physiologically competitive with inorganic and organic acids. Suitable acids are hydrochloric acid, phosphoric acid, hydrogenation, sulfuric acid, lactic acid, citric acid, tartaric acid, oxalic acid and maleic acid.

구조식(II)에서 (V)까지의 화합물은 문헌을 통해 알려진 기지의 방법에 의해 각각 제조된다. 예를 들어 구조식(II)화합물은 구조식(VI)의 상응하는 0-할로겐-카복실산이 초산구리의 촉매 및 나트륨 에톡시드와 같은 나트륨알콕시드의 존재하에서 60 내지 100℃사이의 온도로 구조식(VII)의 케톤과 반응하여 제조된다. 계속하여 수득된 구조식(VIII)의 카복실산을 구조식(V)의 아민으로 처리하여 구조식(IX)의 상응하는 환산 케톤으로 전환시킨다. 수득코자하는 구조식(II)화합물은 R6의 기를 분리한 후 나트륨 에톡시드의 존재하에서 실온으로 디메틸포름아미드 또는 디메틸설폭시드와 같은 용매내에서 상응하는 할로겐에피히드린 또는 상응하는 1-브로모-3-클로로프로판과 반응하여 수득된다.Compounds of formulas (II) to (V) are each prepared by known methods known from the literature. For example, the compound of formula (II) has a structure wherein the corresponding 0-halogen-carboxylic acid of formula (VI) is at a temperature between 60 and 100 ° C. in the presence of a catalyst of copper acetate and sodium alkoxide such as sodium ethoxide. It is prepared by reacting with ketone of. The carboxylic acid of formula (VIII) obtained is then treated with the amine of formula (V) to convert to the corresponding reduced ketone of formula (IX). The desired compound of formula (II) is to separate the group of R 6 and then to the corresponding halogen epihydrin or the corresponding 1-bromo- in a solvent such as dimethylformamide or dimethylsulfoxide at room temperature in the presence of sodium ethoxide. Obtained by reaction with 3-chloropropane.

Figure kpo00004
Figure kpo00004

상기 구조식에서 A, R4,R5및 n 은 상기 정의된 대로이고 Hal은 염소, 취소 또는 요오드원자이고 R6는 메틸 또는 벤질그룹이다.Wherein A, R 4 , R 5 and n are as defined above, Hal is a chlorine, cancel or iodine atom and R 6 is methyl or benzyl group.

구조식(IV)의 출발화합물은 구조식(X)의 상응하는 페녹시유도체가 나트륨에톡시드의 존재하에서 60 내지 100℃의 온도로 구조식(VI)의 상응하는 0-할로겐-카복실산과 반응하여 수득된다.Starting compounds of formula (IV) are obtained by reacting the corresponding phenoxy derivatives of formula (X) with the corresponding 0-halogen-carboxylic acids of formula (VI) at a temperature of 60 to 100 ° C. in the presence of sodium ethoxide. .

Figure kpo00005
Figure kpo00005

상기 구조식에서 A, R1에서 R4까지는 상기 정의된 대로이고 Hal은 염소, 취소 또는 요오드원자이다.In the above structural formula, A, R 1 to R 4 are as defined above and Hal is a chlorine, cancel or iodine atom.

이미 앞서 언급한 바와 같이 신규의 구조식(I)화합물 및 생리적으로 경쟁적으로 산부가염은 가치있는 약학적 활성, 특히 항앙기나성, 항부정맥성 및 β-수용체-차단 효과를 나타낸다.As already mentioned earlier, novel structural (I) compounds and physiologically competitive acid addition salts exhibit valuable pharmaceutical activity, in particular antiangina, antiarrhythmic and β-receptor-blocking effects.

다음의 화합물은 생물학적 활성에 관하여 시험되었다.The following compounds were tested for biological activity.

A=2-메틸-3-[4-(2-하이드록시-3-3급부틸아미노-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1-(2H)-온, B=2-메틸-3-[2-(2-하이드록시-3-이소프로필아미노-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1-(2H)-온-옥살레이트, C =2-메틸-3-[2-(2-하이드록시-3-이소프로필아미노-프로폭시)-4-메톡시-페닐]-7-메톡시-이소퀴놀린-1(2H)-온-옥살레이트, D=2-메틸-3-[2-(2-하이드록시-3-3급부틸아미노-프로폭시)-4-메톡시-페닐]-7-메톡시-이소퀴놀린-1(2 H)-온-옥살레니트, E=2-메틸-3-[4-(2-하이드록시-3-3급부틸아미노-프로폭시)-페닐]-6,7-디메톡시-이소퀴놀린-1(2H)-온, F=2-메틸-3-[3-메톡시-4-(2-하이드록시-3-이소프로필아미노-프로폭시)-페닐]-6,7-디메톡시-이소퀴놀린-1(2H)-온, G=2-메틸-3-[3-메톡시-4-(2-하이드록시-3-이소프로필아미노 -프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온, H=2-메틸-3-[4-(2-하이드록시-3-이소프로필아미노-프로폭시)-펜에틸]-7-메톡시-이소퀴놀린-1(2H)-온.A = 2-Methyl-3- [4- (2-hydroxy-3-tert-butylamino-propoxy) -phenyl] -7-methoxy-isoquinolin-1- (2H) -one, B = 2 -Methyl-3- [2- (2-hydroxy-3-isopropylamino-propoxy) -phenyl] -7-methoxy-isoquinolin-1- (2H) -one-oxalate, C = 2- Methyl-3- [2- (2-hydroxy-3-isopropylamino-propoxy) -4-methoxy-phenyl] -7-methoxy-isoquinolin-1 (2H) -one-oxalate, D = 2-Methyl-3- [2- (2-hydroxy-3-tert-butylamino-propoxy) -4-methoxy-phenyl] -7-methoxy-isoquinolin-1 (2H) -one Oxalenite, E = 2-methyl-3- [4- (2-hydroxy-3-tert-butylamino-propoxy) -phenyl] -6,7-dimethoxy-isoquinoline-1 (2H) -One, F = 2-methyl-3- [3-methoxy-4- (2-hydroxy-3-isopropylamino-propoxy) -phenyl] -6,7-dimethoxy-isoquinoline-1 ( 2H) -one, G = 2-methyl-3- [3-methoxy-4- (2-hydroxy-3-isopropylamino-propoxy) -phenyl] -7-methoxy-isoquinoline-1 ( 2H) -one, H = 2-methyl-3- [4- (2-hydroxy-3-iso Propylamino-propoxy) -phenethyl] -7-methoxy-isoquinolin-1 (2H) -one.

1) 혈액순환에 대한 효과1) Effects on blood circulation

혈액 순환에 대한 시험은 체중 19 내지 30kg의 개에게 클로라로즈-우레탄-넴부탈-아나에스데시아(54+270+10mg/kg)을 정맥내 주사하여 수행한다.Tests for blood circulation are performed by intravenously injecting Chlorrose-Urethane-Nembutal-Anasedesia (54 + 270 + 10 mg / kg) into dogs weighing 19-30 kg.

4번째 좌측 늑간공내에서 흉곽을 연후 하바드 호흡기구로 공기를 공급한다. 동맥혈압은 경동맥으로부터 스타탐-압력 교환기로 측정하고 심장 박동수는 심전도상의 R-편차의 결과로 부터 전자적으로 결정한다. 좌측위 내에서 증가하는 압력의 극대속도 (dp/dt max)는 케닉스베르크-압력장치(konigsberg-pressure-apparatus )및 그래스-미분치(Grass-diffevential gauge)에 의해 측정된다.Open the rib cage in the fourth left intercostal cavity and supply air to the Harvard breathing apparatus. Arterial blood pressure is measured from the carotid artery with a statam-pressure exchanger and heart rate is determined electronically from the result of the R-deviation on the electrocardiogram. The maximum velocity of increasing pressure (dp / dt max) in the upper left is measured by the Konigsberg-pressure-apparatus and the Grass-diffevential gauge.

모든 매개변수는 직접적 기록에 의해 표기된다. 항응고작용을 위해 20%의 폴리디올에 용해한 폴리에틸렌 설폰산칼륨 10mg/kg을 동물에게 정맥내 주사한다. 4 내지 6마리의 개에게 시험할 물질을 정맥내로 주사한다. 다음 표는 얻어진 수치를 나타낸다.All parameters are indicated by direct documentation. Animals are injected intravenously with 10 mg / kg of polyethylene sulfonate dissolved in 20% polydiol for anticoagulant action. Four to six dogs are injected intravenously with the material to be tested. The following table shows the numerical values obtained.

Figure kpo00006
Figure kpo00006

2) 기니아 피그의 분리된 심방의 수축력 및 박동수에 대한 효과2) Effect of guinea pigs on contractile force and heart rate of isolated atrium

자발적으로 박동하는 기니아 피그로부터 분리한 심방을 37℃에서 카보겐(95% O2+5% CO2)을 용해한 크렙스-헨셀라이트 용액을 저장하고 다시 시험할 물질의 본 농도에 저장한 후 극대로 전달되는 장력(등장성 수축력) 및 박동수를 측정한다.Atrial isolated from spontaneously beating guinea pigs was stored at 37 ° C. in a Krebs-Hencelite solution in which carbogen (95% O 2 + 5% CO 2 ) was dissolved and again at this concentration of the material to be tested. The tension (isotropic contractile force) and the beat rate transmitted are measured.

Figure kpo00007
Figure kpo00007

3) 급성 독성의 결정3) determination of acute toxicity

시험할 물옥의 급성독성은 새앙쥐에게 경구투여 및 정맥내 주사한 후 결정된다.(관찰기간 : 14일)The acute toxicity of the waters to be tested is determined after oral and intravenous injections into new rats (observation period: 14 days).

LD50은 관찰기간동안 여러가지 복용량을 투여한 후 죽은 동물의 백분율로부터 측정된다.LD 50 is determined from the percentage of animals that died after the various doses were administered during the observation period.

Figure kpo00008
Figure kpo00008

본 발명에 따라 수득된 신규의 구조식(I)화합물은 관상중 및 저혈압증의 치료에 적절하다.The novel structural formula (I) compounds obtained according to the invention are suitable for the treatment of coronary and hypotension.

약학적으로 투여하기 위해 신규의 구조식(I)화합물은 정제, 당제, 분말, 현탁액, 용매, 또는 좌약과 같은 통상의 생약제제 형태인 다른 효과적인 물질과 결합될 수 있다.For pharmaceutical administration, the novel compounds of formula (I) can be combined with other effective substances in the form of conventional herbal preparations such as tablets, sugars, powders, suspensions, solvents, or suppositories.

성인에 대한 1회 복용량은 50 내지 250mg정도이다.Single doses for adults range from 50 to 250 mg.

다음의 실시예는 본 발명을 설명한다. 신규 화합물의 화학적 구조는 IR-, UV-, MNR-스펙트라 및 원소분석에 의해 결정된다.The following examples illustrate the invention. The chemical structure of the new compound is determined by IR-, UV-, MNR-spectra and elemental analysis.

[실시예 1]Example 1

[2-메틸-3-[4-(2-하이드록시-3-3급부틸아미노-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (2-hydroxy-3-tert-butylamino-propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

a) 2-메틸-3-[4-(2,3-에콕시프로폭시)-페닐]-7-메톡시-이소퀴놀린-1 (2H)-온a) 2-methyl-3- [4- (2,3-epoxypropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one

20ml의 디메틸설폭시드에 용해한 2.8g(10m 몰)의 2-메틸-3-(4-하이드록시-페닐)-7-메톡시-이소퀴놀린-1(2H)-온 용액에 1.35g(10m 몰+20%)의 칼륨 -3급 부톡시드를 교반하며 가하고 잠시후 칼륨염을 침전시킨다. 2.8ml의 에피브로모 하이드린을 가한다. 반응이 종결될 때까지 실온에서 교반한 후 혼합물을 빙수에 붓고 결정성 침전을 흡인 여과하고 세척한 다음 건조시킨다.1.35 g (10 m mol) in 2.8 g (10 mmol) 2-methyl-3- (4-hydroxy-phenyl) -7-methoxy-isoquinolin-1 (2H) -one solution dissolved in 20 ml of dimethyl sulfoxide + 20%) potassium tert-butoxide is added with stirring and after a while the potassium salt is precipitated. 2.8 ml of epibromo hydrin is added. After stirring at room temperature until the reaction is complete, the mixture is poured into ice water and the crystalline precipitate is suction filtered, washed and dried.

수득량 : 2.86g(이론치의 85%)Yield: 2.86 g (85% of theory)

융 점 : 153 내지 155℃Melting Point: 153 ~ 155 ℃

C19H20NO4(337.37)C 19 H 20 NO 4 (337.37)

계산치 : C 71.70, H 5.68, N 4.15Calculated Value: C 71.70, H 5.68, N 4.15

실측치 : 71.14 5.65 4.10Found: 71.14 5.65 4.10

b) 2-메틸-3-[4-(2-하이드록시-3-3급 부틸아미노-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온b) 2-methyl-3- [4- (2-hydroxy-3-tert-butylamino-propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one

실시예 1a)에 따라 수득된 에폭시드 2.55g(7.5m 몰)을 밀폐된 용기내에서 25ml의 3급 부틸아민과 함께 120℃까지 가열한다. 2시간후 사용된 과량의 아민을 진공하에서 제거하고 수득된 과립상의 잔사를 아세톤으로부터 재결정한다.2.55 g (7.5 m mole) of epoxide obtained according to example 1a) is heated to 120 ° C. with 25 ml of tertiary butylamine in a closed vessel. After 2 hours the excess amine used is removed under vacuum and the granular residue obtained is recrystallized from acetone.

수득량 : 2.1g(이론치의 70%) 융 점 : 130 내지 131℃Yield: 2.1 g (70% of theory) Melting point: 130 to 131 ° C

C24H30N2O4(410.51)C 24 H 30 N 2 O 4 (410.51)

계산치 : C 70.22, H 7.32, N 6.82Calculated Value: C 70.22, H 7.32, N 6.82

실측치 : 69.90 7.29 6.75Found: 69.90 7.29 6.75

[실시예 2]Example 2

[2-메틸-3-[4-(2-하이드록시-3-(3,4-디메톡시페닐-N-에틸-아미노)-프로폭시-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (2-hydroxy-3- (3,4-dimethoxyphenyl-N-ethyl-amino) -propoxy-phenyl] -7-methoxy-isoquinoline-1 ( 2H) -on]

실시예 1a)에 따라 수득된 2-메틸-3-[4-(2,3-에폭시프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 1.4g(5m 몰)을 140℃에서 3,4-디메톡시페닐-N-에틸-에틸아민 1.5g과 반응시킨 후 생성된 조성물을 실리카겔 컬럼(입도 0.2 내지 0.5mm, 용출제 :클로로포름 : 메탄올=19 : 1)으로 여과한다. 수득된 생성물을 증발한 후 아세톤에 용해시키고 옥살레이트로 에테르성 옥살산을 사용하여 침전시킨다.1.4 g (5 m mol) of 2-methyl-3- [4- (2,3-epoxypropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one obtained according to example 1a) The resulting composition was reacted with 1.5 g of 3,4-dimethoxyphenyl-N-ethyl-ethylamine at 140 ° C. and the resulting composition was filtered through a silica gel column (particle size: 0.2 to 0.5 mm, eluent: chloroform: methanol = 19: 1). do. The product obtained is evaporated and then dissolved in acetone and precipitated using etheric oxalic acid as oxalate.

수득율 : 이론치의 76.5g(옥살레이트로 수득)Yield: 76.5 g of theoretical value (obtained with oxalate)

융 점 : 152 내지 155℃(메탄올로부터)Melting Point: 152-155 ° C (From Methanol)

C34H40N2O10(636.30)C 34 H 40 N 2 O 10 (636.30)

계산치 : C 64.14, H 6.33, N 4.40Calculated Value: C 64.14, H 6.33, N 4.40

실측치 : 63.86 6.46 4.36Found: 63.86 6.46 4.36

[실시예 3]Example 3

[2-메틸-3-[4-(3-(3,4-디메톡시페닐-N-메틸-에틸아미노)-프로폭시-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (3,4-dimethoxyphenyl-N-methyl-ethylamino) -propoxy-phenyl] -7-methoxy-isoquinolin-1 (2H) -one ]

a) 2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H )-온a) 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one

20ml의 디메틸설폭시드에 용해한 2.8g(10m 몰)의 2-메틸-3-(4-하이드록시-페닐)-7-메톡시-이소퀴놀린-1(2H)-온 용액에 칼륨-3급 부톡시드 1.35g(10 m 몰+20%)을 가한 다음 잠시후 칼륨염을 침전시킨다. 2.8ml의 1-브로모-3-클로로프로판을 혼합물에 가하고 실온에서 교반을 계속한다. 반응이 종결된후 반응 용액을 얼음물에 붓고 에틸아세테이트로 추출한다. 유기추출물을 황산나트륨으로 건조시키고 진공하에서 증발시킨다. 수득된 무색오일을 응고하고 아세톤/에테르로부터 재결정한다.Potassium tert-butoxide in 2.8 g (10 mmol) 2-methyl-3- (4-hydroxy-phenyl) -7-methoxy-isoquinolin-1 (2H) -one solution dissolved in 20 ml of dimethyl sulfoxide 1.35 g (10 m mol + 20%) of the seed is added and after a while the potassium salt is precipitated. 2.8 ml of 1-bromo-3-chloropropane is added to the mixture and stirring is continued at room temperature. After the reaction is completed, the reaction solution is poured into iced water and extracted with ethyl acetate. The organic extract is dried over sodium sulfate and evaporated in vacuo. The colorless oil obtained is coagulated and recrystallized from acetone / ether.

수득량 : 3.2g(이론치의 89.6%)Yield: 3.2 g (89.6% of theory)

융 점 : 102 내지 104℃Melting Point: 102-104 ℃

C20H20ClNO3(357.83)C 20 H 20 ClNO 3 (357.83)

계산치 : C 67.13, H 5.63, N 3.91, Cl 9.90Calculated Value: C 67.13, H 5.63, N 3.91, Cl 9.90

실측치 : 66.97 5.61 3.96 9.65Found: 66.97 5.61 3.96 9.65

b) 2-메틸-3-[4-(3-3,4-디메톡시페닐-N-메틸-에틸아미노)-프로폭시)페닐]-7-메톡시-이소퀴놀린-1(2H)-온b) 2-methyl-3- [4- (3-3,4-dimethoxyphenyl-N-methyl-ethylamino) -propoxy) phenyl] -7-methoxy-isoquinolin-1 (2H) -one

실시예 3a)에 따라 수득된 1.8g(5m 몰)의 염화프로필을 140℃에서 1.8g의 3,4-디메톡시페닐-N-메틸-에틸아민과 반응시킨후 수득된 조생성물을 실리카겔컬럼 (입도 : 0.2 내지 0.5mm, 용출제 : 클로로포름 : 메탄올=19 : 1)으로 여과한다. 수득된 생성물을 증발한 후 아세톤에 용해시키고 에테르성 염산으로 침전시킨다.The crude product obtained after reacting 1.8 g (5 mmol) of propyl chloride obtained according to Example 3a) with 1.8 g of 3,4-dimethoxyphenyl-N-methyl-ethylamine at 140 ° C. was subjected to silica gel column ( Particle size: 0.2 to 0.5 mm, eluent: chloroform: methanol = 19: 1) filtered. The product obtained is evaporated and then dissolved in acetone and precipitated with etheric hydrochloric acid.

수득량 : 1.45g(이론치의 52.5%)염산염으로 수득Yield: 1.45 g (52.5% of theory) obtained by hydrochloride

융 점 : 155 내지 160℃(아세톤으로부터)Melting Point: 155-160 ° C. (from Acetone)

C31H37ClN2O5(553.09)C 31 H 37 ClN 2 O 5 (553.09)

계산치 : C 67.32, H 6.74, N 5.07, Cl 6.41Calculated Value: C 67.32, H 6.74, N 5.07, Cl 6.41

실측치 : 67.00 6.84 4.98 6.31Found: 67.00 6.84 4.98 6.31

[실시예 4]Example 4

[2-메틸-3-[4-(2-하이드록시-3-이소프로필 아미노-프로폭시)-페닐]-7 -메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (2-hydroxy-3-isopropyl amino-propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-2,3-에폭시프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 및 이소프로필아민으로부터 반응온도를 50℃까지 올려가면서 실시예 1과 유사하게 생성한다.Example 2-methyl-3- [4-2,3-epoxypropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and isopropylamine raising the reaction temperature to 50 ° C Produce similar to 1.

수득율 : 이론치의 63%Yield: 63% of theory

융 점 : 140 내지 142℃Melting Point: 140 to 142 ° C

C23H28N2O4(396.48)C 23 H 28 N 2 O 4 (396.48)

계산치 : C 69.68, H 7.12, N 7.06Calculated Value: C 69.68, H 7.12, N 7.06

실측치 : 69.38 7.14 7.10Found: 69.38 7.14 7.10

[실시예 5]Example 5

[2-메틸-3-[4-(2-하이드록시-3-(3,4-디메톡시 페닐에틸 아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (2-hydroxy-3- (3,4-dimethoxy phenylethyl amino) -propoxy) -phenyl] -7-methoxy-isoquinoline-1 (2H)- On]

2-메틸-3-[4-(2,3-에폭시프로폭시)-7-페녹시-메톡시-이소퀴놀린-1( 2H)-온 및 3,4-디메톡시-페닐에틸아민으로부터 실시예 2와 유사한 방법에 따라 생성한다.Example from 2-methyl-3- [4- (2,3-epoxypropoxy) -7-phenoxy-methoxy-isoquinolin-1 (2H) -one and 3,4-dimethoxy-phenylethylamine Produced according to a method similar to 2.

수득율 : 이론치의 71% (옥살레이트로 생성)Yield: 71% of theory (produced by oxalate)

융 점 : 208 내지 210℃(아세톤으로부터)Melting Point: 208 to 210 ° C (from acetone)

C32H36N2O10(608.64)C 32 H 36 N 2 O 10 (608.64)

계산치 : C 63.14, H 5.96, N 4.59Calculated Value: C 63.14, H 5.96, N 4.59

실측치 : 62.68 5.90 4.49Found: 62.68 5.90 4.49

[실시예 6]Example 6

[2-메틸-3-[2-(2-하이드록시-3-이소프로필아미노-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [2- (2-hydroxy-3-isopropylamino-propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[2-(2,3-에폭시프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 및 이소프로필아민으로부터 실시예 1과 유사한 방법에 따라 제조된다.Prepared according to the method similar to Example 1 from 2-methyl-3- [2- (2,3-epoxypropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and isopropylamine do.

수득율 : 이론치의 82.8% (옥살레이트로 수득)Yield: 82.8% of theory (obtained with oxalate)

융 점 : 216 내지 218℃(메탄올로부터)Melting Point: 216-218 ° C. (From Methanol)

C25H30N2O8(486.50)C 25 H 30 N 2 O 8 (486.50)

계산치 : C 61.72, H 6.22, N 5.76Calculated Value: C 61.72, H 6.22, N 5.76

실측치 : 61.70 6.33 6.18Found: 61.70 6.33 6.18

[실시예 7]Example 7

[2-메틸-3-[2-(2-하이드록시-3-이소프로필 아미노-프로폭시)-4-메톡시-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [2- (2-hydroxy-3-isopropyl amino-propoxy) -4-methoxy-phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

200℃까지 반응온도를 올려서 2-메틸-3-[2-(2,3-에폭시프로폭시)-4-메톡시-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 및 이소프로필아민으로부터 실시예 1과 유사한 방법에 따라 제조된다.Reaction temperature is raised to 200 ° C. to 2-methyl-3- [2- (2,3-epoxypropoxy) -4-methoxy-phenyl] -7-methoxy-isoquinolin-1 (2H) -one and iso Prepared according to a method similar to Example 1 from propylamine.

수득율 : 이론치의 88% (옥살레이트로 수득)Yield: 88% of theory (obtained with oxalate)

융 점 : 165 내지 168℃(메탄올로부터)Melting Point: 165-168 ° C. (From Methanol)

C26H32N2O9(516.55)C 26 H 32 N 2 O 9 (516.55)

계산치 : C 60.45, H 6.24, N 5.42Calculated Value: C 60.45, H 6.24, N 5.42

실측치 : 61.28 6.16 5.38Found: 61.28 6.16 5.38

[실시예 8]Example 8

[2-메틸-3-[2-(2-하이드록시-3-3급부틸아미노-프로폭시)-4-메톡시-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [2- (2-hydroxy-3-tert-butylamino-propoxy) -4-methoxy-phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[2-(2,3-에폭시프로폭시)-4-메톡시-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 및 3급 부틸아민으로부터 실시예 1과 유사한 방법에 따라 제조된다.Example 1 from 2-methyl-3- [2- (2,3-epoxypropoxy) -4-methoxy-phenyl] -7-methoxy-isoquinolin-1 (2H) -one and tertiary butylamine It is prepared according to a similar method.

수득율 : 이론치의 90% (옥살레이트로 수득)Yield: 90% of theory (obtained with oxalate)

융 점 : 115 내지 120℃(아세톤/에테르로부터)Melting point: 115 to 120 ° C. (from acetone / ether)

C27H34N2O9(530.55)C 27 H 34 N 2 O 9 (530.55)

계산치 : C 61.12, H 6.46, N 5.28Calculated Value: C 61.12, H 6.46, N 5.28

실측치 : 60.91 6.32 5.19Found: 60.91 6.32 5.19

[실시예 9]Example 9

[2-메틸-3-[4-(2-하이드록시-3-3급 부틸아미노-프로폭시)-페닐]-6,7 -디메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (2-hydroxy-3-tert-butylamino-propoxy) -phenyl] -6,7-dimethoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(2,3-에폭시프로폭시)-페닐]-6,7-디메톡시-이소퀴놀린-1(2H)-온 및 3급 부틸아민으로부터 실시예 1과 유사한 방법에 따라 제조된다.Similar method as Example 1 from 2-methyl-3- [4- (2,3-epoxypropoxy) -phenyl] -6,7-dimethoxy-isoquinolin-1 (2H) -one and tertiary butylamine Manufactured according to.

수득율 : 이론치의 65%Yield: 65% of theory

융 점 : 165 내지 166℃(아세톤/에테르로부터)Melting Point: 165-166 ° C. (from Acetone / Ether)

C25H32N2O5(440.53)C 25 H 32 N 2 O 5 (440.53)

계산치 : C 68.15, H 7.32, N 6.36Calculated Value: C 68.15, H 7.32, N 6.36

실측치 : 67.70 7.23 6.41Found: 67.70 7.23 6.41

[실시예 10]Example 10

[2-메틸-3-[4-(2-하이드록시-3-이소프로필아미노-프로폭시)-페닐]-6,7-디메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (2-hydroxy-3-isopropylamino-propoxy) -phenyl] -6,7-dimethoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(2,3-에폭시프로폭시)-페닐]-6,7-디메톡시-이소퀴놀린-1(2H)-온 및 이소프로필아민으로부터 실시예 1과 유사한 방법에 따라 제조된다.In a method similar to Example 1 from 2-methyl-3- [4- (2,3-epoxypropoxy) -phenyl] -6,7-dimethoxy-isoquinolin-1 (2H) -one and isopropylamine Are manufactured accordingly.

수득율 : 이론치의 81%Yield: 81% of theory

융 점 : 206 내지 207℃(아세톤/에티르로부터)Melting Point: 206-207 ° C (from Acetone / Ethyr)

C24H30N2O5(426.50)C 24 H 30 N 2 O 5 (426.50)

계산치 : C 67.58, H 7.09, N 6.57Calculated Value: C 67.58, H 7.09, N 6.57

실측치 : 67.36 7.02 6.63Found: 67.36 7.02 6.63

[실시예 11]Example 11

[2-메틸-3-[3-메톡시-4-(2-하이드록시-3-이소프로필아미노프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [3-methoxy-4- (2-hydroxy-3-isopropylaminopropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[3-메톡시-4-(2,3-에폭시프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 및 이소프로필아민으로부터 실시예 1과 유사한 방법에 따라 제조된다.Example 1 from 2-methyl-3- [3-methoxy-4- (2,3-epoxypropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and isopropylamine Prepared according to a similar method.

수득율 : 이론치의 77%Yield: 77% of theory

융 점 : 144 내지 146℃(아세톤으로부터)Melting Point: 144-146 ° C (From Acetone)

C24H30N2O5(426.507)C 24 H 30 N 2 O 5 (426.507)

계산치 : C 67.58, H 7.09, N 6.57Calculated Value: C 67.58, H 7.09, N 6.57

실측치 : 67.35 7.15 6.76Found: 67.35 7.15 6.76

[실시예 12]Example 12

2-메틸-3-[3-메톡시-4-(2-하이드록시-3-(2-메톡시페닐에틸-아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온2-Methyl-3- [3-methoxy-4- (2-hydroxy-3- (2-methoxyphenylethyl-amino) -propoxy) -phenyl] -7-methoxy-isoquinoline-1 ( 2H) -on

2-메틸-3-[3-메톡시-4-(2,3-에폭시프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 및 2-메톡시페닐에틸아민으로부터 실시예 2와 유사한 방법에 따라 제조된다.From 2-methyl-3- [3-methoxy-4- (2,3-epoxypropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 2-methoxyphenylethylamine It is prepared according to a method similar to that of Example 2.

수득율 : 이론치의 56% (옥살레이트로 수득)Yield: 56% of theory (obtained with oxalate)

융 점 : 197 내지 199℃(메탄올로 부터)Melting Point: 197 to 199 ° C (From Methanol)

C32H36N2O10(680.65)C 32 H 36 N 2 O 10 (680.65)

계산치 : C 63.18, H 6.04, N 4.60Calculated Value: C 63.18, H 6.04, N 4.60

실측치 : 63.40 6.11 4.56Found: 63.40 6.11 4.56

[실시예 13]Example 13

[2-메틸-3-[4-(2-하이드록시-3-이소프로필아미노-프로폭시)-펜에틸]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (2-hydroxy-3-isopropylamino-propoxy) -phenethyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(2,3-에폭시프로폭시)-펜에틸]-7-메톡시-이소퀴놀린-1(2H)-온 및 이소프로필아민으로부터 실시예 1과 유사한 방법에 따라 제조된다.From 2-methyl-3- [4- (2,3-epoxypropoxy) -phenethyl] -7-methoxy-isoquinolin-1 (2H) -one and isopropylamine according to a similar method as in Example 1 Are manufactured.

수득율 : 이론치의 77%Yield: 77% of theory

융 점 : 137 내지 139℃(아세톤/에테르로부터)Melting Point: 137-139 DEG C (from Acetone / Ether)

계산치 : C 70.75, H 7.59, N 6.60Calculated Value: C 70.75, H 7.59, N 6.60

실측치 : 70.40 7.48 6.61Found: 70.40 7.48 6.61

[실시예 14]Example 14

[2-메틸-3-[3-메톡시-4-(2-하이드록시-3-이소프로필아미노프로폭시)-펜에틸]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [3-methoxy-4- (2-hydroxy-3-isopropylaminopropoxy) -phenethyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[3-메톡시-4-(2,3-이폭스프로폭시)-펜에틸]-7-메톡시-이소퀴놀린-1(2H)-온 및 이소프로필아민으로부터 실시예 1과 유사한 방법에 따라 제조된다.Example 1 from 2-methyl-3- [3-methoxy-4- (2,3-epoxypropoxy) -phenethyl] -7-methoxy-isoquinolin-1 (2H) -one and isopropylamine It is prepared according to a similar method.

수득율 : 이론치의 80%Yield: 80% of theory

융 점 : 162 내지 164℃(아세톤/에테르로부터)Melting Point: 162-164 DEG C (from Acetone / Ether)

C26H24N2O5(454.56)C 26 H 24 N 2 O 5 (454.56)

계산치 : C 68.70, H 7.54, N 6.16Calculated Value: C 68.70, H 7.54, N 6.16

실측치 : 68.60 7.54 6.03Found: 68.60 7.54 6.03

[실시예 15]Example 15

[2-메틸-3-[3-메톡시-4-(3-(2-0-메톡시-페닐-에틸아미노)-2-하이드록시)-프로폭시)-페닐에틸]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [3-methoxy-4- (3- (2-0-methoxy-phenyl-ethylamino) -2-hydroxy) -propoxy) -phenylethyl] -7-methoxy Isoquinolin-1 (2H) -one]

2-메틸-3-[3-메톡시-4-(2,3-에폭시프로폭시)-펜에틸]-7-메톡시-이소퀴놀린-1(2H)-온 및 2-메톡시페닐-에틸아민으로부터 실시예 2과 유사한 방법에 따라 제조된다.2-Methyl-3- [3-methoxy-4- (2,3-epoxypropoxy) -phenethyl] -7-methoxy-isoquinolin-1 (2H) -one and 2-methoxyphenyl-ethyl Prepared according to a method analogous to Example 2 from amines.

수득율 : 이론치의 74%Yield: 74% of theory

융 점 : 117 내지 118℃(아세톤으로부터)Melting Point: 117-118 DEG C (from Acetone)

C32H38N2O6(546.67)C 32 H 38 N 2 O 6 (546.67)

계산치 : C 70.30, H 7.01, N 5.13Calculated Value: C 70.30, H 7.01, N 5.13

실측치 : 70.20 7.03 5.04Found: 70.20 7.03 5.04

[실시예 16]Example 16

[2-메틸-3-[4-(2-하이드록시-3-3급 부틸아미노-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (2-hydroxy-3-tert-butylamino-propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(2,3-에폭시프로폭시)-페닐]-이소퀴놀린-1(2H)-온 및 3급 부틸아민으로부터 실시예 1과 유사하게 제조된다.Prepared analogously to Example 1 from 2-methyl-3- [4- (2,3-epoxypropoxy) -phenyl] -isoquinolin-1 (2H) -one and tertiary butylamine.

수득율 : 이론치의 84%Yield: 84% of theory

융 점 : 130 내지 132℃(아세톤/에테르로부터)Melting point: 130 to 132 ° C. (from acetone / ether)

C23H28N2O3(380.48)C 23 H 28 N 2 O 3 (380.48)

계산치 : C 72.61, H 7.42, N 7.36Calculated Value: C 72.61, H 7.42, N 7.36

실측치 : 72.80 7.48 7.22Found: 72.80 7.48 7.22

[실시예 17]Example 17

[2-메틸-3-[4-(3-메톡시페닐-N-메틸-에틸아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3-methoxyphenyl-N-methyl-ethylamino) -propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H )-온 및 4-메톡시페닐-N-페닐에틸아민으로부터 실시예 3에 따라 유사하게 제조된다.Example 3 from 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 4-methoxyphenyl-N-phenylethylamine Accordingly prepared accordingly.

수득율 : 이론치의 75% (염산염으로 수득)Yield: 75% of theory (obtained by hydrochloride)

융 점 : 229 내지 23℃(아세톤/에테르로부터)Melting Point: 229-23 ° C. (from Acetone / Ether)

C30H35ClN2O4(523.07)C 30 H 35 ClN 2 O 4 (523.07)

계산치 : C 68.88, H 6.75, N 5.36 Cl 6.78Calculated Value: C 68.88, H 6.75, N 5.36 Cl 6.78

실측치 : 68.60 6.70 5.36 6.82Found: 68.60 6.70 5.36 6.82

[실시예 18]Example 18

[2-메틸-3-[4-(3-(3,4,5-트리메톡시페닐-N-메틸-에틸아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (3,4,5-trimethoxyphenyl-N-methyl-ethylamino) -propoxy) -phenyl] -7-methoxy-isoquinoline-1 ( 2H) -on]

2-메틸-3-[4-(3-클로로프로폭시)-페녹시]-7-메톡시-이소퀴놀린-1(2 H)-온 및 3,4,5-트리메톡시페닐-N-메틸-에틸아민으로부터 실시예 3에 따라 유사하게 제조된다.2-Methyl-3- [4- (3-chloropropoxy) -phenoxy] -7-methoxy-isoquinolin-1 (2H) -one and 3,4,5-trimethoxyphenyl-N- Similarly prepared according to Example 3 from methyl-ethylamine.

수득율 : 이론치의 53% (옥살레이트로 수득)Yield: 53% of theory (obtained with oxalate)

융 점 : 224 내지 225℃(메탄올로부터)Melting Point: 224-225 ° C. (From Methanol)

C34H440N2O10(636.68)C 34 H4 40 N 2 O 10 (636.68)

계산치 : C 64.13, H 6.33, N 4.40Calculated Value: C 64.13, H 6.33, N 4.40

실측치 : 63.71 6.19 4.55Found: 63.71 6.19 4.55

[실시예 19]Example 19

[2-메틸-3-[4-(3-(2-하이드록시-3-0-크레실-프로필아미노-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (2-hydroxy-3-0-cresyl-propylamino-propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one ]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H )-온 및 2-하이드록시-3-0-크레실-프로필아민으로부터 실시예 3에 따라 유사하게 제조된다.From 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 2-hydroxy-3-0-cresyl-propylamine Similarly prepared according to Example 3.

수득율 : 이론치의 70% (옥살레이트로 수득)Yield: 70% of theory (obtained with oxalate)

융 점 : 178 내지 182℃(메탄올로부터)Melting Point: 178-182 ° C (From Methanol)

C32H36N2O9(592.65)C 32 H 36 N 2 O 9 (592.65)

계산치 : C 64.85, H 6.12, N 4.73Calculated Value: C 64.85, H 6.12, N 4.73

실측치 : 64.50 6.21 4.66Found: 64.50 6.21 4.66

[실시예 20]Example 20

[2-메틸-3-[4-(3-(2-하이드록시-3-P-크레실-프로필아미노)-프로폭시-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (2-hydroxy-3-P-cresyl-propylamino) -propoxy-phenyl] -7-methoxy-isoquinolin-1 (2H) -one ]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H )-온 및 2-하이드록시-3-P-크레실-프로필아민으로부터 실시예 3에 따라 유사하게 제조된다.From 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 2-hydroxy-3-P-cresyl-propylamine Similarly prepared according to Example 3.

수득율 : 이론치의 64% (옥살레이트로 수득)Yield: 64% of theory (obtained with oxalate)

융 점 : 195 내지 197℃(메탄올로부터)Melting Point: 195-197 ° C. (From Methanol)

C32H36N2O9(592.65)C 32 H 36 N 2 O 9 (592.65)

계산치 : C 64.85, H 6.12, N 4.73Calculated Value: C 64.85, H 6.12, N 4.73

실측치 : 64.70 6.13 4.83Found: 64.70 6.13 4.83

[실시예 21]Example 21

[2-메틸-3-[4-(3-(2-하이드록시-3-0-메톡시페녹시-프로필아미노)-프로폭시-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (2-hydroxy-3-0-methoxyphenoxy-propylamino) -propoxy-phenyl] -7-methoxy-isoquinoline-1 (2H) -On]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H )-온 및 2-하이드록시-3-0-메톡시-페녹시-프로필아민으로부터 실시예 3에 따라 유사하게 제조된다.2-Methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 2-hydroxy-3-0-methoxy-phenoxy- Similarly prepared according to Example 3 from propylamine.

수득율 : 이론치의 77% (옥살레이트로 수득)Yield: 77% of theory (obtained with oxalate)

융 점 : 156 내지 158℃(메탄올로부터)Melting Point: 156-158 DEG C (from Methanol)

C32H36N2O10(608.65)C 32 H 36 N 2 O 10 (608.65)

계산치 : C 63.14, H 5.96, N 4.60Calculated Value: C 63.14, H 5.96, N 4.60

실측치 : 62.78 5.74 4.59Found: 62.78 5.74 4.59

[실시예 22]Example 22

[2-메틸-3-[4-(3-(2-하이드록시-3-P-메톡시페녹시-프로필아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (2-hydroxy-3-P-methoxyphenoxy-propylamino) -propoxy) -phenyl] -7-methoxy-isoquinoline-1 (2H )-On]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H )-온 및 2-하이드록시-3-P-메톡시-페녹시-프로필아민으로부터 실시예 3에 따라 유사하게 제조된다.2-Methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 2-hydroxy-3-P-methoxy-phenoxy- Similarly prepared according to Example 3 from propylamine.

수득율 : 이론치의 77% (옥살레이트로 수득)Yield: 77% of theory (obtained with oxalate)

융 점 : 172 내지 175℃(메탄올로부터)Melting Point: 172-175 ° C (From Methanol)

C32H36N2O10(608.65)C 32 H 36 N 2 O 10 (608.65)

계산치 : C 61.72, H 6.22, N 5.76Calculated Value: C 61.72, H 6.22, N 5.76

실측치 : 61.70 6.33 6.18Found: 61.70 6.33 6.18

[실시예 23]Example 23

[2-메틸-3-[4-(3-(2-메톡시페닐-에틸아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (2-methoxyphenyl-ethylamino) -propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 및 2-메톡시페닐-에틸-아민으로부터 실시예 3에 따라 유사하게 제조된다.According to Example 3 from 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 2-methoxyphenyl-ethyl-amine Similarly made.

수득율 : 이론치의 67% (옥살레이트로 수득)Yield: 67% of theory (obtained with oxalate)

융 점 : 216 218℃(메탄올로부터)Melting Point: 216 218 ° C (From Methanol)

C31H34N2O8(562.60)C 31 H 34 N 2 O 8 (562.60)

계산치 : C 66.18, H 6.09, N 4.98Calculated Value: C 66.18, H 6.09, N 4.98

실측치 : 66.10 6.18 4.85Found: 66.10 6.18 4.85

[실시예 24]Example 24

[2-메틸-3-[4-(3-(3-아미노프로필아미아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (3-aminopropylamiamino) -propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H )-온 및 1,3-디아미노프로판으로부터 실시예 3에 따라 유사하게 제조된다.Similarly according to Example 3 from 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 1,3-diaminopropane Are manufactured.

수득율 : 이론치의 50.8% (디옥살레이트로 수득)Yield: 50.8% of theory (obtained with dioxalate)

융 점 : 220 내지 225℃(메탄올로부터)Melting Point: 220-225 ° C (From Methanol)

C27H33N3O11(575.56)C 27 H 33 N 3 O 11 (575.56)

계산치 : C 58.50, H 5.95, N 6.45Calculated Value: C 58.50, H 5.95, N 6.45

실측치 : 58.333 5.87 6.30Found: 58.333 5.87 6.30

[실시예 25]Example 25

[2-메틸-3-[4-(3-(2-하이드록시-3-페녹시-프로필아미노)-프로폭시-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (2-hydroxy-3-phenoxy-propylamino) -propoxy-phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 및 2-하이드록시-3-페녹시-프로필아민으로부터 실시예 3에 따라 유사하게 제조된다.Example from 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 2-hydroxy-3-phenoxy-propylamine Similarly prepared according to 3.

수득율 : 이론치의 73% (옥살레이트로 수득)Yield: 73% of theory (obtained with oxalate)

융 점 : 170 내지 175℃(메탄올로부터)Melting Point: 170-175 ° C. (From Methanol)

C31H34N2O9(578.60)C 31 H 34 N 2 O 9 (578.60)

계산치 : C 64.35, H 5.92, N 4.84Calculated Value: C 64.35, H 5.92, N 4.84

실측치 : 63.70 5.96 4.89Found: 63.70 5.96 4.89

[실시예 26]Example 26

[2-메틸-3-[4-(3-(2-하이드록시-2-페닐-에틸아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (2-hydroxy-2-phenyl-ethylamino) -propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 및 2-하이드록시-2-페닐-에틸-아민으로부터 실시예 3에 따라 유사하게 제조된다.Example from 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 2-hydroxy-2-phenyl-ethyl-amine Similarly prepared according to 3.

수득율 : 이론치의 74% (옥살레이트로 수득)Yield: 74% of theory (obtained with oxalate)

융 점 : 215 220℃(메탄올로부터)Melting Point: 215 220 ℃ (From Methanol)

C30H32N2O8(458.55)C 30 H 32 N 2 O 8 (458.55)

계산치 : C 65.68, H 5.88, N 5.11Calculated Value: C 65.68, H 5.88, N 5.11

실측치 : 65.83 5.88 5.26Found: 65.83 5.88 5.26

[실시예 27]Example 27

[2-메틸-3-[4-(3-(2-아미노-에틸아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (2-amino-ethylamino) -propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온 및 1,2-디아미노-에탄으로부터 실시예 3에 따라 유사하게 제조된다.Similar to Example 3 from 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 1,2-diamino-ethane Is manufactured.

수득율 : 이론치의 73% (디옥살레이트로 수득)Yield: 73% of theory (obtained with dioxalate)

융 점 : 235 내지 240℃(메탄올로부터)Melting Point: 235-240 ° C. (From Methanol)

C26H31N3O11(561.56)C 26 H 31 N 3 O 11 (561.56)

계산치 : C 5.651, H 5.56, N 7.46Calculated Value: C 5.651, H 5.56, N 7.46

실측치 : 55.87 5.64 7.38Found: 55.87 5.64 7.38

[실시예 28]Example 28

[2-메틸-3-[4-(3-(3-m-톨루이딘-프로필아미노-프로폭시)-페닐]-7 -메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (3-m-toluidine-propylamino-propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H )-온 및 3-m-톨루이딘프로필아민으로부터 실시예 3에 따라 유사하게 제조된다.Similarly according to Example 3 from 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and 3-m-toluidinepropylamine Are manufactured.

수득율 : 이론치의 50% (염화수소로 수득)Yield: 50% of theory (obtained from hydrogen chloride)

융 점 : 204 내지 205℃(아세톤로부터)Melting Point: 204-205 DEG C (from Acetone)

C30H36N3O3(522.16)C 30 H 36 N 3 O 3 (522.16)

계산치 : C 69.00, H 6.95, N 8.05 Cl 6.79Calculated Value: C 69.00, H 6.95, N 8.05 Cl 6.79

실측치 : 68.90 7.12 8.03 6.80Found: 68.90 7.12 8.03 6.80

[실시예 29]Example 29

[2-메틸-3-[4-(3-(2-이스프로필옥시카보닐에틸아미노)-프로폭시)-페닐 ]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (2-ispropyloxycarbonylethylamino) -propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H )-온 및 β-아미노프로피오네이트로부터 실시예 3에 따라 유사하게 제조된다.Similarly prepared according to Example 3 from 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and β-aminopropionate do.

수득율 : 이론치의 53% (옥살레이트로 수득)Yield: 53% of theory (obtained with oxalate)

융 점 : 174 175℃(아세톤으로부터)Melting Point: 174 175 ° C (from Acetone)

C28H34N2O9(542.58)C 28 H 34 N 2 O 9 (542.58)

계산치 : C 61.08, H 6.32, N 6.16Calculated Value: C 61.08, H 6.32, N 6.16

실측치 : 61.70 6.53 5.23Found: 61.70 6.53 5.23

[실시예 30]Example 30

[2-메틸-3-[4-(3-(2-이소부틸옥시카보닐에틸아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (2-isobutyloxycarbonylethylamino) -propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-(3-클로로프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H) -온 및 β-아미노프로피오네이트로부터 실시예 3에 따라 유사하게 제조된다.Similarly prepared according to Example 3 from 2-methyl-3- [4- (3-chloropropoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one and β-aminopropionate do.

수득율 : 이론치의 22% (옥살레이트로 수득)Yield: 22% of theory (obtained with oxalate)

융 점 : 190 내지 195℃(아세톤으로부터)Melting point: 190-195 ° C. (from acetone)

C29H36N2O9(556.62)C 29 H 36 N 2 O 9 (556.62)

계산치 : C 62.57, H 6.52, N 5.03Calculated Value: C 62.57, H 6.52, N 5.03

실측치 : 62.90 6.66 5.03Found: 62.90 6.66 5.03

[실시예 31]Example 31

[6-메틸-7-[4-(2-하이드록시-3-(3,4-디메톡시-페닐-N-메틸-에틸아미노)-프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온][6-Methyl-7- [4- (2-hydroxy-3- (3,4-dimethoxy-phenyl-N-methyl-ethylamino) -propoxy) -phenyl] -1,6-naphthyridine- 5 (6H) -on]

6-메틸-7-[4-(2,3-에톡시프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온 및 2-(3,4-디메톡시페닐)-N-메틸-에틸아민으로부터 실시예 2에 따라 유사하게 제조된다.6-methyl-7- [4- (2,3-ethoxypropoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one and 2- (3,4-dimethoxyphenyl) -N Similarly prepared according to example 2 from -methyl-ethylamine.

수득율 : 이론치의 70% (옥살레이트로 수득)Yield: 70% of theory (obtained with oxalate)

융 점 : 85 내지 95℃Melting Point: 85-95 ℃

C31H35N3O9(593.6)C 31 H 35 N 3 O 9 (593.6)

계산치 : C 62.72, H 5.94, N 7.08Calculated Value: C 62.72, H 5.94, N 7.08

실측치 : 62.22 5.95 6.98Found: 62.22 5.95 6.98

[실시예 32]Example 32

[6-메틸-7-[4-(2-하이드록시-3-이소프로필아미노-프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온][6-Methyl-7- [4- (2-hydroxy-3-isopropylamino-propoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one]

6-메틸-7-[4-(2,3-에톡시프로폭시)-페닐]-1,65-나프티리딘-5(6H)-온 및 이소프로필아민으로부터 실시예 1에 따라 유사하게 제조된다.Similarly prepared according to Example 1 from 6-methyl-7- [4- (2,3-ethoxypropoxy) -phenyl] -1,65-naphthyridin-5 (6H) -one and isopropylamine .

수득율 : 이론치의 92%Yield: 92% of theory

융 점 : 135 내지 139℃Melting Point: 135-139 ℃

C21H25N3O2(367.46)C 21 H 25 N 3 O 2 (367.46)

계산치 : C 68.64, H 6.86, N 11.44Calculated Value: C 68.64, H 6.86, N 11.44

실측치 : 67.03 6.69 11.39Found: 67.03 6.69 11.39

[실시예 33]Example 33

[6-메틸-7-[4-(2-하이드록시-3-(3,4-디메톡시-에틸아미노)-프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온][6-Methyl-7- [4- (2-hydroxy-3- (3,4-dimethoxy-ethylamino) -propoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one ]

6-메틸-7-[4-(2,3-에폭시프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온 및 2-(3,4-디메톡시-페닐)-에틸아민으로부터 실시예 2에 따라 유사하게 제조된다.6-Methyl-7- [4- (2,3-epoxypropoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one and 2- (3,4-dimethoxy-phenyl) -ethyl Similarly prepared according to Example 2 from amines.

수득율 : 이론치의 64% (옥살레이트로 수득)Yield: 64% of theory (obtained with oxalate)

융 점 : 82 95℃Melting Point: 82 95 ℃

C40H33N3O9(57.60)C 40 H 33 N 3 O 9 (57.60)

계산치 : C 62.17, H 5.74, N 7.25Calculated Value: C 62.17, H 5.74, N 7.25

실측치 : 61.56 5.80 6.32Found: 61.56 5.80 6.32

[실시예 34]Example 34

[6-메틸-7-[4-(2-하이드록시-3-(4-메톡시페닐-N-메틸-에틸아미노)-프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온][6-Methyl-7- [4- (2-hydroxy-3- (4-methoxyphenyl-N-methyl-ethylamino) -propoxy) -phenyl] -1,6-naphthyridine-5 (6H )-On]

6-메틸-7-[4-(2,3-에톡시프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온 및 2-(4-메톡시페닐)-N-메틸-에틸아민으로부터 실시예 2에 따라 유사하게 제조된다.6-methyl-7- [4- (2,3-ethoxypropoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one and 2- (4-methoxyphenyl) -N-methyl Similarly prepared according to example 2 from ethylamine.

수득율 : 이론치의 61% (옥살레이트로 수득)Yield: 61% of theory (obtained with oxalate)

융 점 : 66 내지 73℃Melting Point: 66 ~ 73 ℃

C30H33N3O8(563.60)C 30 H 33 N 3 O 8 (563.60)

계산치 : C 69.93, H 5.90, N 7.45Calculated Value: C 69.93, H 5.90, N 7.45

실측치 : 63.94 5.75 7.14Found: 63.94 5.75 7.14

[실시예 35]Example 35

[6-메틸-7-[4-(2-하이드록시-3-(3,4,5-트리메톡시-페닐-N-메틸-에틸아미노)-프로폭시)-]-1,6-나프티리딘-5(6H)-온][6-Methyl-7- [4- (2-hydroxy-3- (3,4,5-trimethoxy-phenyl-N-methyl-ethylamino) -propoxy)-]-1,6-naphthy Lidin-5 (6H) -one]

6-메틸-7-[4(2,3-에톡시프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온 및 2-(3,4,5-트리메톡시페닐)-N-메틸-에틸아민으로부터 실시예 2에 따라 유사하게 제조된다.6-methyl-7- [4 (2,3-ethoxypropoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one and 2- (3,4,5-trimethoxyphenyl) Similarly prepared according to example 2 from -N-methyl-ethylamine.

수득율 : 이론치의 35.5% (옥살레이트로 수득)Yield: 35.5% of theory (obtained with oxalate)

융 점 : 87 내지 95℃Melting Point: 87-95 ℃

C32H37N3O10(623.7)C 32 H 37 N 3 O 10 (623.7)

계산치 : C 61.63, H 5.98, N 6.74Calculated Value: C 61.63, H 5.98, N 6.74

실측치 : 61.38 5.84 6.77Found: 61.38 5.84 6.77

[실시예 36]Example 36

[6-메틸-7-[4-(2-하이드록시-3-3급 부틸아미노-프로폭시)-페닐]-1,6 -나프티리딘-5(6H)-온][6-Methyl-7- [4- (2-hydroxy-3-tert-butylamino-propoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one]

6-메틸-7-[4-(2,3-에톡시프로폭시)-페녹시]-1,6-나프티리딘-5(6H)-온 및 3급 부틸아민으로부터 실시예 1에 따라 유사하게 제조된다.Similarly according to Example 1 from 6-methyl-7- [4- (2,3-ethoxypropoxy) -phenoxy] -1,6-naphthyridin-5 (6H) -one and tertiary butylamine Are manufactured.

수득율 : 이론치의 41% (옥살레이트로 수득)Yield: 41% of theory (obtained with oxalate)

융 점 : 248 내지 250℃Melting Point: 248 ~ 250 ℃

C24H29N3O7(471.5)C 24 H 29 N 3 O 7 (471.5)

계산치 : C 61.04, H 6.20, N 8.91Calculated Value: C 61.04, H 6.20, N 8.91

실측치 : 60.70 6.42 8.89Found: 60.70 6.42 8.89

[실시예 37]Example 37

[6-메틸-7-[4-(2-하이드록시-3-디에틸아미노-프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온][6-Methyl-7- [4- (2-hydroxy-3-diethylamino-propoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one]

6-메틸-7-[4-(2,3-에폭시프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온 및 디메틸아민으로부터 실시예 1에 따라 유사하게 제조된다.Similarly prepared according to Example 1 from 6-methyl-7- [4- (2,3-epoxypropoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one and dimethylamine.

수득율 : 이론치의 70% (옥살레이트로 수득)Yield: 70% of theory (obtained with oxalate)

융 점 : 143 내지 145℃Melting Point: 143 ~ 145 ℃

C24H29N3O7(471.4)C 24 H 29 N 3 O 7 (471.4)

계산치 : C 61.14, H 6.20, N 8.91Calculated Value: C 61.14, H 6.20, N 8.91

실측치 : 61.22 6.25 9.01Found: 61.22 6.25 9.01

[실시예 38]Example 38

[6-메틸-7-[4-(3-(3,4-디메톡시-페닐-N-메틸-에틸아미노)-프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온][6-Methyl-7- [4- (3- (3,4-dimethoxy-phenyl-N-methyl-ethylamino) -propoxy) -phenyl] -1,6-naphthyridine-5 (6H)- On]

6-메틸-7-[4-(3-클로로프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온 및 2-(3,4-디메톡시페닐)-N-메틸-에틸아민으로부터 실시예 3에 따라 유사하게 제조된다.6-Methyl-7- [4- (3-chloropropoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one and 2- (3,4-dimethoxyphenyl) -N-methyl- Similarly prepared according to Example 3 from ethylamine.

수득율 : 이론치의 45% (옥살레이트로 수득)Yield: 45% of theory (obtained with oxalate)

융 점 : 167 내지 170℃Melting Point: 167-170 ℃

C31H35N3O8(577.6)C 31 H 35 N 3 O 8 (577.6)

계산치 : C 64.46, H 6.11, N 7.27Calculated Value: C 64.46, H 6.11, N 7.27

실측치 : 64.45 6.16 7.05Found: 64.45 6.16 7.05

[실시예 39]Example 39

[6-메틸-7-[4-(3-(4-메톡시페닐-메틸-에틸아미노)-프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온][6-Methyl-7- [4- (3- (4-methoxyphenyl-methyl-ethylamino) -propoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one]

6-메틸-7-[4-(3-클로로프로폭시)-페닐]-1,6-나프티리딘-5(6H)-온 및 2-(4-메톡시페닐)-N-메틸-에틸아민으로부터 실시예 3에 따라 유사하게 제조된다.6-Methyl-7- [4- (3-chloropropoxy) -phenyl] -1,6-naphthyridin-5 (6H) -one and 2- (4-methoxyphenyl) -N-methyl-ethylamine From Similar according to Example 3.

수득율 : 이론치의 45% (옥살레이트로 수득)Yield: 45% of theory (obtained with oxalate)

융 점 : 188 내지 190℃Melting Point: 188 ~ 190 ℃

C30H33N3O7(547.6)C 30 H 33 N 3 O 7 (547.6)

계산치 : C 65.80, H 6.07, N 7.67Calculated Value: C 65.80, H 6.07, N 7.67

실측치 : 66.72 5.85 7.74Found: 66.72 5.85 7.74

[실시예 40]Example 40

[2-메틸-3-[4-(3-(4-메톡시페닐-N-메틸-에틸아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (4-methoxyphenyl-N-methyl-ethylamino) -propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one]

2-메틸-3-[4-3-(4-메톡시페닐에틸-N-메틸아미노)-프로폭시)-아세토페닐]-5-메톡시-벤조산 2.5g(5m 몰)을 밀폐된 용기내에서 25ml의 메틸아민에 가한다. 50℃로 3시간 가열한 후 과량의 메틸아민을 증류하고 수득된 조생성물을 실리카겔컬럼(입도 : 0.2 내지 0.5mm, 용출제 : 클로로포름 : 메탄올=19:1)으로 여과한다. 증발 후 수득된 잔사를 아세톤에 용해시키고 염화수소로 에테르상의 염화수소산을 가하여 침전시킨다.2.5 g (5 m mol) of 2-methyl-3- [4-3- (4-methoxyphenylethyl-N-methylamino) -propoxy) -acetophenyl] -5-methoxy-benzoic acid in a closed container To 25 ml of methylamine. Excess methylamine was distilled off after heating to 50 degreeC for 3 hours, and the obtained crude product was filtered by the silica gel column (particle size: 0.2-0.5 mm, eluent: chloroform: methanol = 19: 1). The residue obtained after evaporation is dissolved in acetone and precipitated by addition of hydrochloric acid on ether with hydrogen chloride.

수득량 : 1.4g(이론치의 25.6%) (염산염으로 수득)Yield: 1.4 g (25.6% of theory) (obtained by hydrochloride)

융 점 : 226 내지 228℃(아세톤/에테르로부터)Melting point: 226 to 228 ° C. (from acetone / ether)

C30H35ClN2O4(523.07)C 30 H 35 ClN 2 O 4 (523.07)

계산치 : C 68.88, H 6.75, N 5.36 Cl 6.78Calculated Value: C 68.88, H 6.75, N 5.36 Cl 6.78

실측치 : 68.43 6.82 5.39 6.73Found: 68.43 6.82 5.39 6.73

[실시예 41]Example 41

[2-메틸-3-[4-(3-(3,4-메톡시페닐-N-메틸-에틸아미노)-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온][2-Methyl-3- [4- (3- (3,4-methoxyphenyl-N-methyl-ethylamino) -propoxy) -phenyl] -7-methoxy-isoquinoline-1 (2H)- On]

2-[4-(3-(3,4-디메톡시-페닐-에틸-N-메틸-아미노)-프로폭시)-아세토페닐]-5-메톡시-벤조산 및 메틸아민으로부터 반응온도를 200℃까지 올려서 실시예 40에 따라 유사하게 제조된다.The reaction temperature is 200 ° C. from 2- [4- (3- (3,4-dimethoxy-phenyl-ethyl-N-methyl-amino) -propoxy) -acetophenyl] -5-methoxy-benzoic acid and methylamine And similarly prepared according to Example 40.

수득율 : 이론치의 31.6% (염화수소로 수득)Yield: 31.6% of theory (obtained from hydrogen chloride)

융 점 : 157 내지 159℃(아세톤으로부터)Melting Point: 157-159 ° C. (from Acetone)

C31H17ClN2O5(553.09)C 31 H 17 ClN 2 O 5 (553.09)

계산치 : C 67.32 H 6.74 N 5.07 Cl 6.41Calculated Value: C 67.32 H 6.74 N 5.07 Cl 6.41

실측치 : 67.14 6.71 5.12 6.37Found: 67.14 6.71 5.12 6.37

[실시예 A]Example A

100mg의 2-메틸-3-[4-(2-하이드록시-3-3급 부틸아미노-프로폭시)-페닐]-7-메톡시-이소퀴놀린-1(2H)-온을 함유하는 정제Tablets containing 100 mg of 2-methyl-3- [4- (2-hydroxy-3-tert-butylamino-propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one

Figure kpo00009
Figure kpo00009

[제조방법][Manufacturing method]

활성성분 및 락토오즈를 폴리비닐피롤리돈의 수성용액으로 균질하게 습윤시킨 후 스크린을 통과시킨다. 건조 후 입자를 남아 있는 성분과 혼합하고 그 혼합물을 통상의 방법에 의해 압착하여 정제로 만든다.The active ingredient and lactose are homogeneously wetted with an aqueous solution of polyvinylpyrrolidone and then passed through the screen. After drying, the particles are mixed with the remaining ingredients and the mixture is compressed by conventional methods to form a tablet.

[실시예 B]Example B

150mg의 2-메틸-3-〔4-(2-하이드록시-3-이소프로필-아미노-프로폭시)-페닐〕-6, 7-디메톡시-이소퀴놀린-1(2H)-온을 함유하는Containing 150 mg 2-methyl-3- [4- (2-hydroxy-3-isopropyl-amino-propoxy) -phenyl] -6,7-dimethoxy-isoquinolin-1 (2H) -one

[좌약][suppository]

Figure kpo00010
Figure kpo00010

[제조방법][Manufacturing method]

활성성분을 용해된 좌약 질량에 교반하며 가하여 현탁시키고 액상 혼합물을 냉각한 좌약형에 붓는다.The active ingredient is added to the dissolved suppository mass with stirring, suspended and the liquid mixture is poured into a cooled suppository.

[실시예 C]Example C

50mg의 2-메틸-3-〔4-(2-하이드록시-3-3급 부틸아미노-프로폭시)-페닐〕-7-메톡시-이소퀴놀린-1(2H)-온50 mg of 2-methyl-3- [4- (2-hydroxy-3-tert-butylamino-propoxy) -phenyl] -7-methoxy-isoquinolin-1 (2H) -one

Figure kpo00011
Figure kpo00011

[제조방법][Manufacturing method]

혼합물을 실시예 A에 기술된 대로 피막입힌 정제핵으로 제조시킨 후 다시 설탕과 아라비아고무로 피막을 입힌다.The mixture is prepared from the coated tablet cores as described in Example A and then coated with sugar and gum arabic.

[실시예 D]Example D

250mg의 2-메틸-3-[4-(2-하이드록시-3-이소프로필아미노-프로폭시) -페닐]-6,7-디메톡시-이소퀴놀린-1(2H)-온을 함유하는 5ml의 현탁액5 ml containing 250 mg 2-methyl-3- [4- (2-hydroxy-3-isopropylamino-propoxy) -phenyl] -6,7-dimethoxy-isoquinolin-1 (2H) -one Suspension of

Figure kpo00012
Figure kpo00012

[제조방법][Manufacturing method]

벤조산에스테르, 글리세린 및 카복시메틸셀룰로오즈를 70℃까지 가열한 물에 교반하며 용해시킨다. 용액을 실온으로 냉각하고 활성성분을 교반하며 가한 후 균질하게 분산시킨다. 서당을 가하고 용해시킨 후 소르비톨용액 및 향미현탁액을 교반하여 배기시킨다.Benzoic acid ester, glycerin, and carboxymethylcellulose are dissolved in water heated to 70 ° C with stirring. The solution is cooled to room temperature, the active ingredient is added with stirring and homogeneously dispersed. Sucrose is added and dissolved, and the sorbitol solution and the flavor suspension are stirred and evacuated.

Claims (1)

구조식(II)의 프로폭시페닐 유도체가 구조식(III)의 아민과 반응하거나 구조식(IV)의 카복실산 또는 그 유도체가 구조식(V)의 아민과 반응시킴을 특징으로 하는 구조식(I)의 아미노알콕시페닐 유도체 또는 그의 산부가염의 제조방법.The aminoalkoxyphenyl of formula (I) characterized in that the propoxyphenyl derivative of formula (II) reacts with the amine of formula (III) or the carboxylic acid or derivative thereof of formula (IV) reacts with the amine of formula (V) Method for producing a derivative or acid addition salt thereof.
Figure kpo00013
Figure kpo00013
Figure kpo00014
Figure kpo00014
Figure kpo00015
Figure kpo00015
Figure kpo00016
Figure kpo00016
Figure kpo00017
Figure kpo00017
상기 구조식에서 A는 저급알콕시그룹, 아미노-및/또는 니트로그룹 또는 피리딜 그룹으로 모노-, 디- 또는 트리-치환된 페닐기이고 R1은 수소원자 또는 저급알킬기이고 R2는 1 내지 6까지의 탄소원자를 갖는 직쇄 또는 측쇄알킬 그룹이거나 하드록시그룹에 의해 임의 치환되고 1에서 4까지의 탄소원자를 갖는 직쇄포화알킬렌그룹이다. 여기서 알킬렌그룹은 아미노그룹, 2에서 6의 탄소원자를 갖는 카브알콕시그룹, 페닐 또는 페녹시그룹(저급알킬 및/또는 알콕시기에 의해 모노-, 디- 또는 트리-치환된 그룹)에 의해 말단치환된다.Wherein A is a mono-, di- or tri-substituted phenyl group with a lower alkoxy group, an amino- and / or nitro group or a pyridyl group, R 1 is a hydrogen atom or a lower alkyl group and R 2 is from 1 to 6 Linear or branched alkyl groups having carbon atoms or linearly saturated alkylene groups optionally substituted by hydroxy groups and having 1 to 4 carbon atoms. Wherein the alkylene group is terminally substituted by an amino group, a carboalkoxy group having 2 to 6 carbon atoms, a phenyl or phenoxy group (a mono-, di- or tri-substituted group by lower alkyl and / or alkoxy group) . R3는 수소원자 또는 하이드록시그룹이고 R4는 수소원자, 저급알킬 또는 알콕시기그룹이고 R5는 수소원자 또는 저급알킬그룹이고 n은 0,1 또는 2이고 X는 할로겐원자와 같은 친핵적 교환그룹이거나 R3와 함께 산소원자이다.R 3 is a hydrogen atom or a hydroxy group, R 4 is a hydrogen atom, a lower alkyl or alkoxy group, R 5 is a hydrogen atom or a lower alkyl group, n is 0, 1 or 2 and X is a nucleophilic exchange such as a halogen atom Or an oxygen atom together with R 3 .
KR7800157A 1978-01-27 1978-01-27 Process for preparing aminoalkexyphenyl derivative KR810000604B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR7800157A KR810000604B1 (en) 1978-01-27 1978-01-27 Process for preparing aminoalkexyphenyl derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR7800157A KR810000604B1 (en) 1978-01-27 1978-01-27 Process for preparing aminoalkexyphenyl derivative

Publications (1)

Publication Number Publication Date
KR810000604B1 true KR810000604B1 (en) 1981-06-05

Family

ID=19206737

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7800157A KR810000604B1 (en) 1978-01-27 1978-01-27 Process for preparing aminoalkexyphenyl derivative

Country Status (1)

Country Link
KR (1) KR810000604B1 (en)

Similar Documents

Publication Publication Date Title
EP0126449B1 (en) Cardioselective aryloxy- and arylthio-hydroxypropyl piperazinyl acetanilides wich affect calcium entry
US4081447A (en) 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
GB2090249A (en) Fused-ring pyrimidones
US4234584A (en) Substituted phenylpiperazine derivatives
CA1062717A (en) 1-aryloxy-2-hydroxy-3-alkinylaminopropanes and processes for production thereof
US3755413A (en) 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
CA1106846A (en) Aminoalkoxyphenyl-derivatives
FR2459235A1 (en) NOVEL SULFONYL-ANILINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
WO1998000389A1 (en) 2-hydroxypropionic acid derivative and its manufacturing method
US4067904A (en) Alkylsulfonylphenoxypropanolamine derivatives
EP0008645B1 (en) Alkoxyphenylpyrrolidones, process for their preparation and medicaments containing them
EP0034116A2 (en) N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US5084456A (en) Oxazolopyridine compounds
US3574749A (en) 1-(4-amidophenoxy)-3-amino-2-propanol derivatives
KR810000604B1 (en) Process for preparing aminoalkexyphenyl derivative
US5422373A (en) Anti-atherosclerotic aryl compounds
IE43797B1 (en) Esters of indole-derived amino alcohols
SU428602A3 (en) METHOD OF OBTAINING BASIC-SUBSTITUTE DERIVATIVES 1
FR2634207A1 (en) [(4-Piperidyl)methyl]benzazepine derivatives, their preparation and their application in therapeutics
DE3046871A1 (en) 2-Amino:alkoxy-phenyl-quinazolin-4-one derivs. - and -pyrido-pyrimidin-4-one derivs. prepd. by reaction of e.g. halo-alkoxy or epoxy-alkoxy cpds. with amine(s)
FI61694C (en) FRAMEWORK FOR FRAMSTERING OF SUBSTITUTES WITH A BLOOD TRYCKET WITH A SHORT-BASED SAFETY NETWORK
Bell et al. Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides
JP3492433B2 (en) 3- (Phenylalkylaminoalkyloxy) -5-phenylpyrazole compounds, methods and intermediates for their preparation and cardiovascular agents containing them
FR2475540A1 (en) BASIC 4-HYDROXY-BENZOPHENONES ETHERS, THEIR PREPARATION AND THEIR THERAPEUTIC USES
HU194213B (en) Process for production of 3-alkoxi-2-n-pirrolidin-n-piridil-n-furil /or n-tienil/-methil-prophil amins